Serb Pharmaceuticals Agrees To Acquire Y-Mabs Therapeutics

Reuters08-05

Aug 5 (Reuters) - Y-mAbs Therapeutics Inc ::
*SERB PHARMACEUTICALS AGREES TO ACQUIRE Y-MABS THERAPEUTICS
*Y-MABS THERAPEUTICS INC: SERB TO COMMENCE ALL-CASH TENDER OFFER TO ACQUIRE ALL OUTSTANDING SHARES OF Y-MABS FOR $8.60 PER SHARE
*Y-MABS THERAPEUTICS INC - SERB TO BUY Y-MABS IN $412 MILLION DEAL
*Y-MABS THERAPEUTICS INC - SERB OFFERS $8.60 PER SHARE FOR Y-MABS, 105% PREMIUM

((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 05-AUG-202512:30:00.343 GMT

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2557927683?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-05 21:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2557927683","market":"fut","top_or_hot":-1,"title":"Serb Pharmaceuticals Agrees To Acquire Y-Mabs Therapeutics","media":"Reuters","content":"<html><body>Aug 5 (Reuters) - Y-mAbs <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Inc <ymab.o>::<br/>*SERB PHARMACEUTICALS AGREES TO ACQUIRE Y-MABS THERAPEUTICS<br/>*Y-MABS THERAPEUTICS INC: SERB TO COMMENCE ALL-CASH TENDER OFFER TO ACQUIRE ALL OUTSTANDING SHARES OF Y-MABS FOR $8.60 PER SHARE<br/>*Y-MABS THERAPEUTICS INC - SERB TO BUY Y-MABS IN $412 MILLION DEAL<br/>*Y-MABS THERAPEUTICS INC - SERB OFFERS $8.60 PER SHARE FOR Y-MABS, 105% PREMIUM<br/><br/>  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))<br/>  Source Date/Time = 05-AUG-202512:30:00.343 GMT</ymab.o></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Serb Pharmaceuticals Agrees To Acquire Y-Mabs Therapeutics</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSerb Pharmaceuticals Agrees To Acquire Y-Mabs Therapeutics\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-08-05 21:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body>Aug 5 (Reuters) - Y-mAbs <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Inc <ymab.o>::<br/>*SERB PHARMACEUTICALS AGREES TO ACQUIRE Y-MABS THERAPEUTICS<br/>*Y-MABS THERAPEUTICS INC: SERB TO COMMENCE ALL-CASH TENDER OFFER TO ACQUIRE ALL OUTSTANDING SHARES OF Y-MABS FOR $8.60 PER SHARE<br/>*Y-MABS THERAPEUTICS INC - SERB TO BUY Y-MABS IN $412 MILLION DEAL<br/>*Y-MABS THERAPEUTICS INC - SERB OFFERS $8.60 PER SHARE FOR Y-MABS, 105% PREMIUM<br/><br/>  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))<br/>  Source Date/Time = 05-AUG-202512:30:00.343 GMT</ymab.o></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"YMAB","symbol_name":"Y-mAbs Therapeutics, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250805:nRSD8T1vwk:1","article_id":"2557927683","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2557927683","pubTimestamp":1754401361,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Aug 5 (Reuters) - Y-mAbs Therapeutics Inc ::*SERB PHARMACEUTICALS AGREES TO ACQUIRE Y-MABS THERAPEUTICS*Y-MABS THERAPEUTICS INC: SERB TO COMMENCE ALL-CASH TENDER OFFER TO ACQUIRE ALL OUTSTANDING SHARE","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"YMAB":"Y-mAbs Therapeutics, Inc.","BK4139":"生物科技"},"translate_title":"Serb Pharmaceuticals同意收购Y-Mabs Therapeutics","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"YMAB":0.9},"content_text":"Aug 5 (Reuters) - Y-mAbs Therapeutics Inc ::*SERB PHARMACEUTICALS AGREES TO ACQUIRE Y-MABS THERAPEUTICS*Y-MABS THERAPEUTICS INC: SERB TO COMMENCE ALL-CASH TENDER OFFER TO ACQUIRE ALL OUTSTANDING SHARES OF Y-MABS FOR $8.60 PER SHARE*Y-MABS THERAPEUTICS INC - SERB TO BUY Y-MABS IN $412 MILLION DEAL*Y-MABS THERAPEUTICS INC - SERB OFFERS $8.60 PER SHARE FOR Y-MABS, 105% PREMIUM  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 05-AUG-202512:30:00.343 GMT","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2557927683","isCrawlerRequest":true}